Today’s AI Top Pick: VTRS
6/30/2026 · Breakout Leaders Undervalued screen · a free sample of K3vl4r’s AI-curated picks.
AI-ranked from a screened shortlist, with entry strategy, targets, and risks.
View the live VTRS price forecast →
Viatris is the cleanest setup in this pool because it combines a fresh, fundamental positive catalyst with technicals that are NOT extended — a rare pairing in this batch where almost every other name is pinned at 100% of its 21-bar range with deeply negative forward forecasts. On June 29, VTRS announced its VR-205 Phase 3 trial in Japan met both primary and key secondary endpoints with NDA filing planned by end-2026 — a real, dateable de-risking event, not just an analyst note. That is the kind of catalyst that supports a sustained re-rating. The tape confirms the setup is not over-chased. VTRS sits at only 56.16% of its 21-bar range on the 1h, 86.48% on 4h, 77.48% on 1d, and 80.08% on 1wk — meaningfully off the highs (drawdown of -4.78% on the weekly), unlike RPRX, DAL, VLO, DVA, SIRI, and MU which are all parked at 99-100% across multiple timeframes. The weekly recent_21bar_pct is just +4.56% — the most modest run-up in the entire pool versus DVA (+47.5%), DAL (+35.76%), SIRI (+40.5%), MU (+178%). That means the trade isn't a chase; you're buying after a pullback into a confirmed catalyst. The forecast tape is admittedly negative across this whole basket — that's the elephant in the room. But VTRS's near-term forecasts are the LEAST damaging: 1h fc_short +0.14%, 4h fc_short -0.01%, while comparable names like MU show 1d fc_short -55%, DVA -37.58%, STT -21.99%. Near-term-bullish is 0.2 (tied with the best in the group). Combined with the Phase 3 readout and the modest weekly run, this is the only name where I'd argue the negative model forecasts are likely stale relative to the new catalyst. Why today, not wait: the stock is mid-range after a real positive readout that just hit the tape — waiting risks the gap-fill on the catalyst. A clear stop at recent support keeps risk defined.
- Model forecast for 1wk fc_mid is -41.58% and 1d fc_short is -28% — the algorithm sees broader downside; the bull case relies on the Phase 3 catalyst overriding the model
- Pharma sector headline risk: VTRS still has legacy generics pricing pressure and complex P&L cleanup; quarter-to-quarter sales YoY can disappoint
- Catalyst is for Japan NDA filing end-2026 — a long path to revenue, not an immediate cash-flow event
- Position 86.48% on 4h with dd_from_21bar_high only -1.01% suggests near-term 4h pullback risk before next leg
- Whole basket shows uniformly bearish multi-timeframe forecasts — macro/tape risk could overwhelm single-name catalysts
| # | Symbol | Verdict | Score | Read |
|---|---|---|---|---|
| 1 | VTRS | BUY NOW | 6.8 | Phase 3 success on Jun 29 + only +4.56% weekly run + 56% range position = best risk/reward catalyst trade in the pool. |
| 2 | BPOP | BUY NOW | 6.2 | Multiple sell-side PT hikes ($188-190); cleanest pullback entry at 15.91% of 1h range; near-term bullish 0.2. |
| 3 | STT | BUY NOW | 5.9 | Morgan Stanley OW $183; rare positive 1h/4h fc_short; not at top of range on shorter TFs. |
| 4 | DAL | BUY PULLBACK | 5.4 | Citi target raise + Buffett tailwind, but 100% of 1d/1wk range and 1d fc_short -35.74% — wait for dip. |
| 5 | BMO | BUY PULLBACK | 5.1 | Scotia PT raise; 1h forecasts only -0.06%; but +25.88% weekly run and 100% range — overextended. |
| 6 | ALGT | BUY PULLBACK | 5.0 | Citi upgrade to Buy $156 on Sun Country deal narrative; weekly only +2.61% so not chased, but 1d run +28% is hot. |
| 7 | BAP | BUY PULLBACK | 4.8 | Zacks upgrade to Buy; multi-TF forecasts negative and at 100% of 1wk range — needs pullback. |
| 8 | RPRX | WAIT | 4.6 | 100% of range across ALL four timeframes — most extended in pool despite near-term bullish 0.2; insider sold. |
| 9 | CVS | WAIT | 4.5 | GLP-1 narrative positive, fresh high — but +33% weekly run and 1d fc_short -33.48% says wait. |
| 10 | TEX | WAIT | 4.3 | Q1 revenue beat but margins lagged; 100% of 1wk range and 1d run +26%; no near-term bullish signal. |
| 11 | BEN | WAIT | 4.1 | Crypto pivot via 250 Digital is interesting but no near-term bullish, and all forecasts negative. |
| 12 | VLO | WAIT | 4.0 | Solid balance sheet narrative but +33.68% weekly run, 100% range, and 1d fc_short -30.72%. |
| 13 | CPA | WAIT | 3.9 | Evercore PT $200 supportive but weekly fc_long -46.79% and tape softening on the day. |
| 14 | KTB | WAIT | 3.8 | Quality screen pass + 'Strong Sell' headline cross-current; modest forecasts but no bullish signal. |
| 15 | DVA | WAIT | 3.5 | 100% of range on ALL TFs, +47.5% weekly run — extreme outlier, classic blow-off risk. |
| 16 | SIRI | WAIT | 3.4 | +40.5% weekly run at 100% range; one of the few with positive 1wk fc_mid (+18%) but already chased. |
| 17 | CPRX | WAIT | 3.3 | Zero-debt quality screen but 1d fc_short -28% and weekly +29% run — no fresh catalyst. |
| 18 | MFG | AVOID | 3.0 | 4h range position 0% and weekly fc_mid -61.37% — broken short-term tape, BOJ rate uncertainty. |
| 19 | PBI | AVOID | 2.8 | +77.4% weekly run is a parabola; weekly fc_mid -61% — textbook late-stage chase. |
| 20 | MRX | AVOID | 2.5 | 1h drawdown -10.6% and 4h range pos 0.26% — short-term structure breaking down. |
| 21 | NESR | AVOID | 2.2 | Weekly fc_mid -71% and fc_long -68.5%; +36.77% weekly run at 100% range — extreme blow-off risk. |
| 22 | MU | AVOID | 1.5 | +178% weekly run, weekly fc_mid/long -87%/-88%; market cap implies $1.29T which is implausible — data integrity concern on top of extreme extension. |
Get AI top picks & forecasts on any stock
K3vl4r screens the market daily and ranks the best setups with AI — forecasts, scored fundamentals & technicals, and multi-horizon price targets. Create a free account to explore them all.
Create your free account →Already a member? Sign in · Join our Discord